(MedPage Today) — The ultimate irony: A lung cancer researcher was denied treatment for advanced lung cancer. (Stanford Daily)
The diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) has surpassed the cancer agent pembrolizumab (Keytruda…
Source link : https://www.medpagetoday.com/hematologyoncology/lungcancer/118263
Author :
Publish date : 2025-10-31 19:02:00
Copyright for syndicated content belongs to the linked Source.
